✦ LIBER ✦
Dose Selection for a Direct and Selective Factor IXa Inhibitor and its Complementary Reversal Agent: Translating Pharmacokinetic and Pharmacodynamic Properties of the REG1 System to Clinical Trial Design
✍ Scribed by T. J. Povsic; M. G. Cohen; M. Y. Chan; S. L. Zelenkofske; W. A. Wargin; R. A. Harrington; J. H. Alexander; C. P. Rusconi; R. C. Becker
- Publisher
- Springer US
- Year
- 2011
- Tongue
- English
- Weight
- 277 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0929-5305
No coin nor oath required. For personal study only.